Showing 891-900 of 3315 results for "".
Using Evidence in Clinical Care to Improve Patient Outcomes
https://modernod.com/topics/business/using-evidence-in-clinical-care-to-improve-patient-outcomes/38045/A breakdown of the concepts associated with patient-centered care and shared decision-making.The Ins and Outs of Retinal Detachments
https://modernod.com/topics/retina/the-ins-and-outs-of-retinal-detachments/37982/Ensure that there are no missing pieces in your knowledge base with this overview.COLLAB CORNER - Managing Patient Expectations for Refractive Procedures
https://modernod.com/podcasts/collaborative-corner-the-podcast/collab-corner-managing-patient-expectations-for-refractive-procedures/36887/Marc R. Bloomenstein, OD, FAAO, invites Justin Schweitzer, OD, FAAO, to discuss collaborative care of patients undergoing refractive surgery. Dr. Schweitzer shares his decision tree for recommending specific refractive procedures in different patient cases, including LASIK, implantable collamer lensMyopia Management as a Solid Business Foundation
https://modernod.com/topics/business/myopia-management-as-a-solid-business-foundation/48763/Stepping into this clinical niche can lead to substantial financial growth, not to mention the benefit to your pediatric patients.The One Big, Beautiful Bill Act, Explained
https://modernod.com/topics/business/the-one-big-beautiful-bill-act-explained/39831/Practice owners: Get ready to make the most out of this new tax legislation.Cornea Health Diagnostic Tools
https://modernod.com/empower-business-specialty-care-optometric-series/septemberoctober-2025-supplement/cornea-health-diagnostic-tools/39814/Daily contact lens patients live their best lives when providers match their anatomy and needs to the lens that fits them best.Lumithera CEO Discusses FDA Authorization for Veleda for Dry AMD
https://modernod.com/podcasts/eyewire-news-the-podcast/lumithera-ceo-discusses-fda-authorization-for-veleda-for-dry-amd/37059/The CEO of Lumithera joins us to discuss the FDA authorization of the Veleda system for dry AMD; the FDA accepts the resubmitted NDA for dry eye disease candidate reproxalap; and Alcon launches the first contact lens designed for a 1-week replacement cycle.Keep Your IOL Knowledge Sharp
https://modernod.com/podcasts/the-mod-pod/keep-your-iol-knowledge-sharp/36888/On this month's episode of The MOD Pod Cecelia Koetting, OD, FAAO, Dipl ABO, welcomes guests Eugene Shifrin, OD, FAAO, and Thomas Chester, OD. Dr. Shifrin shares tips and best practices for enhancing patient outcomes with light adjustable lenses, which he details in a recent article in Modern OptomeNorlase Launches First Pattern Scanning LIO
https://modernod.com/podcasts/eyewire-news-the-podcast/norlase-launches-first-pattern-scanning-lio/37069/The world’s first and only pattern scanning laser indirect ophthalmoscope is approved in the US and Europe; the European Commission approves a biosimilar to Eylea; and we review several clinical updates in the development of ophthalmic drugs. Learn more about your ad choices. Visit megaphone.fm/adchWeekly Headlines: Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap
https://modernod.com/podcasts/eyewire-news-the-podcast/eyewire-news-08142024/37045/Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap • Lensar Receives European Approval for ALLY System • Lenz Therapeutics Submits NDA for Presbyopia Eye Drop